CDC42 and amyotrophic lateral sclerosis: Our previous proteomics study in ALS mouse models have revealed that CDC42 has significant differences between pre-onset and age-matched wild type group, and onset and pre-onset group (Zhang et al., 2018), which indicated it might be important in the regulatory mechanisms of ALS.